দাবিত্যাগ: এটি আইনি পরামর্শ নয়। আইন ও মামলা আইন পরিবর্তন হয়। আপনার নির্দিষ্ট পরিস্থিতির জন্য সর্বদা একজন যোগ্য আইনজীবীর সাথে পরামর্শ করুন।

সব মামলা
Intellectual Property
Supreme Court
2017

Actavis UK Ltd v Eli Lilly & Co

[2017] UKSC 48

Ratio Decidendi

Patent infringement should be assessed in two stages: (1) does the variant infringe on a normal (purposive) interpretation of the claim? (2) if not, does the variant nonetheless infringe because it varies from the invention in a way that is immaterial? The reformulated Improver/Protocol questions apply to the second stage.

তথ্য

Eli Lilly held a patent for pemetrexed disodium, a cancer treatment. Actavis sought to market a product using pemetrexed diacid, a different salt form.

রায়ের সারসংক্ষেপ

The Supreme Court held the Actavis product infringed. Lord Neuberger reformulated the approach to equivalents, holding that a two-stage test applies and that the doctrine of equivalents is part of English patent law.

মূল উদ্ধৃতি

"The problem of infringement must be approached by addressing two issues, each relating to the scope of the monopoly: (i) does the variant infringe any of the claims as a matter of normal interpretation? (ii) if not, does the variant nonetheless infringe because it varies from the invention in a way or ways which is or are immaterial?"

Lord Neuberger

পরবর্তী ব্যবহার

Good law

The leading authority on patent infringement by equivalents in UK law.